CTCX
Price
$2.40
Change
-$0.06 (-2.44%)
Updated
Apr 15, 6:59 PM EST
URGN
Price
$15.11
Change
+$0.01 (+0.07%)
Updated
Apr 15, 2:59 PM EST
23 days until earnings call
Ad is loading...

Compare predictions CTCX vs URGN

Header iconCTCX vs URGN Comparison
Open Charts CTCX vs URGNBanner chart's image
Carmell
Price$2.40
Change-$0.06 (-2.44%)
Volume$5.24K
CapitalizationN/A
UroGen Pharma
Price$15.11
Change+$0.01 (+0.07%)
Volume$20.58K
CapitalizationN/A
View a ticker or compare two or three
CTCX vs URGN Comparison Chart

Loading...

URGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CTCX vs. URGN commentary
Apr 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTCX is a StrongSell and URGN is a Sell.

COMPARISON
Comparison
Apr 16, 2024
Stock price -- (CTCX: $2.50 vs. URGN: $14.18)
Brand notoriety: CTCX and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTCX: 31% vs. URGN: 41%
Market capitalization -- CTCX: $59.09M vs. URGN: $483.85M
CTCX [@Biotechnology] is valued at $59.09M. URGN’s [@Biotechnology] market capitalization is $483.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTCX’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • CTCX’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CTCX is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

URGN’s TA Score shows that 4 TA indicator(s) are bullish.

  • URGN’s TA Score: 4 bullish, 5 bearish.

Price Growth

CTCX (@Biotechnology) experienced а -8.50% price change this week, while URGN (@Biotechnology) price change was -14.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.71%. For the same industry, the average monthly price growth was +6.49%, and the average quarterly price growth was +103.81%.

Reported Earning Dates

URGN is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+4.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CTCX with price predictions.
OPEN
A.I.dvisor published
a Summary for URGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
URGN($484M) has a higher market cap than CTCX($59.1M). URGN YTD gains are higher at: -5.467 vs. CTCX (-34.383). CTCX has higher annual earnings (EBITDA): -19.92M vs. URGN (-81.9M). URGN has more cash in the bank: 137M vs. CTCX (7.97M). CTCX has less debt than URGN: CTCX (9.71M) vs URGN (99.4M). URGN has higher revenues than CTCX: URGN (82.7M) vs CTCX (3.73M).
CTCXURGNCTCX / URGN
Capitalization59.1M484M12%
EBITDA-19.92M-81.9M24%
Gain YTD-34.383-5.467629%
P/E RatioN/AN/A-
Revenue3.73M82.7M5%
Total Cash7.97M137M6%
Total Debt9.71M99.4M10%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
URGN
RSI
ODDS (%)
Bullish Trend 16 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 16 days ago
72%
Momentum
ODDS (%)
Bearish Trend 16 days ago
88%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
85%
Advances
ODDS (%)
Bullish Trend 23 days ago
80%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
83%
Aroon
ODDS (%)
Bearish Trend 16 days ago
87%
View a ticker or compare two or three
Ad is loading...
URGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMLPX36.00N/A
N/A
Goldman Sachs MLP Energy Infras Instl
PFGRX32.90N/A
N/A
Pioneer Fundamental Growth R
PSGKX20.38N/A
N/A
BlackRock Advantage Small Cap Gr K
YFSIX16.56N/A
N/A
AMG Yacktman Global I
JDDVX11.27-0.06
-0.53%
Janus Henderson U.S. Dividend Income D

CTCX and

Correlation & Price change

A.I.dvisor tells us that CTCX and URGN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTCX and URGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTCX
1D Price
Change %
CTCX100%
-2.34%
URGN - CTCX
26%
Poorly correlated
-5.47%
VRCA - CTCX
22%
Poorly correlated
N/A
BCDA - CTCX
22%
Poorly correlated
-2.70%
RVMD - CTCX
20%
Poorly correlated
-1.71%
KOD - CTCX
20%
Poorly correlated
-15.59%
More

URGN and

Correlation & Price change

A.I.dvisor tells us that URGN and TARS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that URGN and TARS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
-5.47%
TARS - URGN
32%
Poorly correlated
-1.38%
EIGR - URGN
31%
Poorly correlated
-72.33%
AVRO - URGN
28%
Poorly correlated
N/A
SNDX - URGN
28%
Poorly correlated
-0.17%
ORMP - URGN
28%
Poorly correlated
-3.08%
More